Panagora Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-53,152
| Closed | -$111K | – | 1546 |
|
|
2022
Q1 | $111K | Sell |
53,152
-236,327
| -82% | -$494K | ﹤0.01% | 1497 |
|
|
2021
Q4 | $1.14M | Buy |
289,479
+325
| +0.1% | +$1.28K | 0.01% | 861 |
|
|
2021
Q3 | $1.39M | Buy |
289,154
+15,420
| +6% | +$74.2K | 0.01% | 820 |
|
|
2021
Q2 | $1.26M | Buy |
273,734
+101,861
| +59% | +$467K | 0.01% | 893 |
|
|
2021
Q1 | $1.01M | Buy |
171,873
+7,822
| +5% | +$45.9K | 0.01% | 1018 |
|
|
2020
Q4 | $561K | Buy |
164,051
+474
| +0.3% | +$1.62K | ﹤0.01% | 1183 |
|
|
2020
Q3 | $236K | Buy |
163,577
+108,574
| +197% | +$157K | ﹤0.01% | 1446 |
|
|
2020
Q2 | $110K | Sell |
55,003
-75,119
| -58% | -$150K | ﹤0.01% | 1754 |
|
|
2020
Q1 | $254K | Buy |
+130,122
| New | +$254K | ﹤0.01% | 1381 |
|
|
2013
Q4 | – | Sell |
-629
| Closed | -$10K | – | 2219 |
|
|
2013
Q3 | $10K | Hold |
629
| – | – | ﹤0.01% | 2256 |
|
|
2013
Q2 | $10K | Buy |
+629
| New | +$10K | ﹤0.01% | 2247 |
|